# SCYNEXIS, Inc. (SCYX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SCYX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -21.30M | $ -8.10M | $ 2.06M | $ 41.31M |
| 2025 | $ 21.09M | $ -8.81M | $ -5.41M | $ 2.18M | $ 49.38M |
| 2024 | $ 3.94M | $ -22.38M | $ -21.02M | $ 16.27M | $ 55.08M |
| 2023 | $ 151.53M | $ 72.49M | $ 65.05M | $ 15.08M | $ 72.96M |
| 2022 | $ 5.69M | $ -70.16M | $ -68.49M | $ 48.60M | $ 3.23M |
| 2021 | $ 15.65M | $ -39.07M | $ -66.25M | $ 43.63M | $ 41.26M |
| 2020 | $ 0 | $ -70.30M | $ -62.88M | $ 19.84M | $ 22.76M |
| 2019 | $ 156.2K | $ -69.33M | $ -49.20M | $ 14.88M | $ 12.90M |
| 2018 | $ 338.1K | $ -16.46M | $ -38.15M | $ 15.08M | $ 31.23M |
| 2017 | $ 344.9K | $ -33.76M | $ -33.08M | $ 14.65M | $ 21.41M |
| 2016 | $ 352.2K | $ -41.26M | $ -40.42M | $ 14.25M | $ 34.82M |
| 2015 | $ 4.90M | $ -45.81M | $ -35.29M | $ 0 | $ 41.95M |
| 2014 | $ 26.88M | $ -5.98M | $ -14.38M | $ 0 | $ 33.43M |
| 2013 | $ 23.97M | $ -43.32M | $ -6.74M | $ 15.00M | $ -8.70M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.88 |
| Current Ratio | 3.94 |

## Other views

- [Metrics](https://sponda.capital/en/SCYX.md)
- [Charts](https://sponda.capital/en/SCYX/charts.md)
- [Compare](https://sponda.capital/en/SCYX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.